Literature DB >> 17230217

Mitochondrial oxidative metabolism is required for the cardiac differentiation of stem cells.

Susan Chung1, Petras P Dzeja, Randolph S Faustino, Carmen Perez-Terzic, Atta Behfar, Andre Terzic.   

Abstract

Cardiogenesis within embryos or associated with heart repair requires stem cell differentiation into energetically competent, contracting cardiomyocytes. While it is widely accepted that the coordination of genetic circuits with developmental bioenergetics is critical to phenotype specification, the metabolic mechanisms that drive cardiac transformation are largely unknown. Here, we aim to define the energetic requirements for and the metabolic microenvironment needed to support the cardiac differentiation of embryonic stem cells. We demonstrate that anaerobic glycolytic metabolism, while sufficient for embryonic stem cell homeostasis, must be transformed into the more efficient mitochondrial oxidative metabolism to secure cardiac specification and excitation-contraction coupling. This energetic switch was programmed by rearrangement of the metabolic transcriptome that encodes components of glycolysis, fatty acid oxidation, the Krebs cycle, and the electron transport chain. Modifying the copy number of regulators of mitochondrial fusion and fission resulted in mitochondrial maturation and network expansion, which in turn provided an energetic continuum to supply nascent sarcomeres. Disrupting respiratory chain function prevented mitochondrial organization and compromised the energetic infrastructure, causing deficient sarcomerogenesis and contractile malfunction. Thus, establishment of the mitochondrial system and engagement of oxidative metabolism are prerequisites for the differentiation of stem cells into a functional cardiac phenotype. Mitochondria-dependent energetic circuits are thus critical regulators of de novo cardiogenesis and targets for heart regeneration.

Entities:  

Mesh:

Year:  2007        PMID: 17230217      PMCID: PMC3232050          DOI: 10.1038/ncpcardio0766

Source DB:  PubMed          Journal:  Nat Clin Pract Cardiovasc Med        ISSN: 1743-4297


  36 in total

Review 1.  The end of the beginning for pluripotent stem cells.

Authors:  P J Donovan; J Gearhart
Journal:  Nature       Date:  2001-11-01       Impact factor: 49.962

2.  Structural adaptation of the nuclear pore complex in stem cell-derived cardiomyocytes.

Authors:  Carmen Perez-Terzic; Atta Behfar; Annabelle Méry; Jan M A van Deursen; Andre Terzic; Michel Pucéat
Journal:  Circ Res       Date:  2003-01-30       Impact factor: 17.367

3.  The fine structure of human embryonic stem cells.

Authors:  Henry Sathananthan; Martin Pera; Alan Trounson
Journal:  Reprod Biomed Online       Date:  2002 Jan-Feb       Impact factor: 3.828

4.  Energetic communication between mitochondria and nucleus directed by catalyzed phosphotransfer.

Authors:  Petras P Dzeja; Ryan Bortolon; Carmen Perez-Terzic; Ekshon L Holmuhamedov; Andre Terzic
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-15       Impact factor: 11.205

Review 5.  Phosphotransfer networks and cellular energetics.

Authors:  Petras P Dzeja; Andre Terzic
Journal:  J Exp Biol       Date:  2003-06       Impact factor: 3.312

Review 6.  Transcriptional regulatory circuits controlling mitochondrial biogenesis and function.

Authors:  Daniel P Kelly; Richard C Scarpulla
Journal:  Genes Dev       Date:  2004-02-15       Impact factor: 11.361

Review 7.  Molecular embryogenesis of the heart.

Authors:  Margaret L Kirby
Journal:  Pediatr Dev Pathol       Date:  2002-09-26

8.  Stem cell differentiation requires a paracrine pathway in the heart.

Authors:  Atta Behfar; Leonid V Zingman; Denice M Hodgson; Jean-Michel Rauzier; Garvan C Kane; Andre Terzic; Michel Pucéat
Journal:  FASEB J       Date:  2002-10       Impact factor: 5.191

9.  Mitochondrial deficiency and cardiac sudden death in mice lacking the MEF2A transcription factor.

Authors:  Francisco J Naya; Brian L Black; Hai Wu; Rhonda Bassel-Duby; James A Richardson; Joseph A Hill; Eric N Olson
Journal:  Nat Med       Date:  2002-10-15       Impact factor: 53.440

10.  Energy metabolism in pig oocytes and early embryos.

Authors:  R G Sturmey; H J Leese
Journal:  Reproduction       Date:  2003-08       Impact factor: 3.906

View more
  205 in total

1.  5-Aminoimidazole-4-carboxyamide ribonucleoside induces G(1)/S arrest and Nanog downregulation via p53 and enhances erythroid differentiation.

Authors:  Hee-Don Chae; Man-Ryul Lee; Hal E Broxmeyer
Journal:  Stem Cells       Date:  2012-02       Impact factor: 6.277

Review 2.  Mitochondrial morphology and cardiovascular disease.

Authors:  Sang-Bing Ong; Derek J Hausenloy
Journal:  Cardiovasc Res       Date:  2010-07-14       Impact factor: 10.787

3.  Mesenchymal stem cells: engineering regeneration.

Authors:  Atta Behfar; Andre Terzic
Journal:  Clin Transl Sci       Date:  2008-05       Impact factor: 4.689

Review 4.  Interactome of a cardiopoietic precursor.

Authors:  Randolph S Faustino; Andre Terzic
Journal:  J Cardiovasc Transl Res       Date:  2008-06-03       Impact factor: 4.132

5.  ATP-sensitive K(+) channel-deficient dilated cardiomyopathy proteome remodeled by embryonic stem cell therapy.

Authors:  Jelena Zlatkovic-Lindor; D Kent Arrell; Satsuki Yamada; Timothy J Nelson; Andre Terzic
Journal:  Stem Cells       Date:  2010-08       Impact factor: 6.277

Review 6.  Energy metabolism in the acquisition and maintenance of stemness.

Authors:  Clifford D L Folmes; Andre Terzic
Journal:  Semin Cell Dev Biol       Date:  2016-02-08       Impact factor: 7.727

Review 7.  Eat, breathe, ROS: controlling stem cell fate through metabolism.

Authors:  Dieter A Kubli; Mark A Sussman
Journal:  Expert Rev Cardiovasc Ther       Date:  2017-04-21

8.  Developmental restructuring of the creatine kinase system integrates mitochondrial energetics with stem cell cardiogenesis.

Authors:  Susan Chung; Petras P Dzeja; Randolph S Faustino; Andre Terzic
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

9.  Embryonic stem cell therapy of heart failure in genetic cardiomyopathy.

Authors:  Satsuki Yamada; Timothy J Nelson; Ruben J Crespo-Diaz; Carmen Perez-Terzic; Xiao-Ke Liu; Takashi Miki; Susumu Seino; Atta Behfar; Andre Terzic
Journal:  Stem Cells       Date:  2008-07-31       Impact factor: 6.277

10.  Nuclear reprogramming with c-Myc potentiates glycolytic capacity of derived induced pluripotent stem cells.

Authors:  Clifford D L Folmes; Almudena Martinez-Fernandez; Randolph S Faustino; Satsuki Yamada; Carmen Perez-Terzic; Timothy J Nelson; Andre Terzic
Journal:  J Cardiovasc Transl Res       Date:  2012-12-18       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.